2Arroyo V,Fernandez J. Management of hepatorenal syndrome in patients with cirrhosis[J]. Nat Rev Nephrol, 2011,7(9) :517-526.
3Boyer T D. Transjugular intrahepatic portosystemic shunt (TIPS): Its time has come[J]. J Clin Gastroenterol,2008,42(5) :437-438.
4Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients.. Meta-analysis update[J]. J Clin Gastroenterol, 2008,42(5):507-516.
5Tzeng W S,Wu R H,Lin C Yet al. Prediction of mortality after emergenttransjugularintrahepatic portosystemic shunt placement: Use of APACHE II, Child-Pugh and MELD scores in asian patients with refractory varicealhemorrhage[J]. Korean J Radiol, 2009,10 (5) : 481-489.
6Boyer T D, Haskal Z J. American Association for the Study of Liver Diseases Practice Guidelines.. The role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension[J]. J Vase Interv Radiol, 2005,16(5): 615-629.
